Catalyst Wire Dossier Catalyst Wire Dossier

DIFFERIN

ADAPALENE · Galderma Laboratories, L.P.
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for DIFFERIN, covering 2007-09-05 to 2022-06-14. Get the full timeline:

Most recent: FDA Approved: DIFFERIN — Supplemental Application (Galderma Laboratories, L.P.)

See pricing